Lexicon Pharmaceuticals, headquartered in The Woodlands, announced it will exclusively license its drug LX9851 to the maker ...

JPMorgan analyst Yang Huang initiated coverage of Ascentage Pharma (AAPG) with an Overweight rating and HK$52 price target The company’s Olverembatinib, having been approved for three CML ...

Rigel Pharmaceuticals (RIGL) announced that it has entered into a settlement agreement with Annora Pharma Private Ltd., Hetero Labs Ltd., and Hetero USA resolving patent litigation related to ...

Looking ahead, this article highlights the key trends expected to shape the regulatory landscape of pharmaceutical manufacturing in 2025. Regulatory agencies—including the U.S. Food and Drug ...

BERLIN, March 28, 2025--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment ...

In his March 17 op-ed, “We should stop acting as if Big Pharma is the big villain in American health care,” Erick Erickson writes, “The government cannot provide clarity or direction for ...

An icon of 3 horizontal dots. An icon of a paper envelope. An icon of a facebook f logo. An icon of a digital camera. An icon of a house. An icon of the Instagram logo. An icon of the LinkedIn logo.

X4 Pharmaceuticals Inc (NASDAQ:XFOR) achieved US approval and launched its first product, XOLREMDI, for WHIM syndrome in 2024. The company has established strong partnerships with Norgine and ...

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.

Perform material- and labor-effective extrusion with Thermo Scientific™ Pharma 11 Twin-screw Extruder, which requires only a small amount of active pharmaceutical ingredient, operating at ...

Over the past two decades, I’ve observed significant shifts in the life sciences, pharmaceutical, and CDMO landscape. Pharmaceutical companies and their outsourcing partners must continuously ...

Healthcare & Pharmaceuticalscategory· March 21, 2025 Alnylam jumps as expanded US approval for heart disease drug fuels growth prospects Alnylam Pharmaceuticals' shares rose more than 10% on ...